News NOW

Al-Saleem Presented with Lifetime Achievement Award

Tahseen-Al-Saleem-revFox Chase Cancer Center pathologist and Temple University Hospital alum Tahseen I. Al-Saleem, MD, has been recognized by the Iraqi Medical Sciences Association with its Lifetime Achievement Award for excellence in medical sciences. In Iraq, Al-Saleem was a professor of pathology and taught students and pathology fellows in the areas of medicine, pathology, and cancer research. He also served as president of the Iraqi Board of Pathology and consulted with the World Health Organization to establish a cancer registry there. Al-Saleem maintains a special emphasis on hematologic and urologic malignancies, has collaborated on the establishment of kidney and prostate cancer databases at Fox Chase, and works closely with the Center’s lymphoma group. His research collaborations include a focus on the molecular genetics and immunology of kidney and prostate cancers, and he has published extensively on the pathology of lymphomas. In addition, he chairs the organizing committee of the Atlantic Regional Hematopathology Meeting, held yearly at Fox Chase.

Caris Designates Fox Chase a Caris Center of Excellence in Precision Medicine

Wafik-El-Deiry-revCaris Life Sciences® has designated Fox Chase Cancer Center a center of excellence site in the Caris Centers of Excellence for Precision Medicine Network™. Wafik El-Deiry, MD, PhD, FACP, deputy cancer center director for translational research and co-program leader of Molecular Therapeutics, will join the Network Steering Committee to establish guidelines and research protocols for tumor profiling. Fox Chase will participate in the development of standards of care and best practices for integrating and utilizing molecular profiling in oncology practice while also striving to increase widespread adoption and patient access to precision medicine in clinical settings. Fox Chase will also leverage Caris’ multiple-technology tumor profiling service, Caris Molecular Intelligence®, to further the Institute’s practice of precision medicine by identifying therapy options and clinical trial opportunities based on the unique characteristics of a patient’s tumor.

Sigurdson Elected to SSO Executive Council

Elin-Sigurdson-revFox Chase Cancer Center surgeon Elin Sigurdson, MD, PhD, FACS, has been elected to the Executive Council of the Society of Surgical Oncology (SSO) for a three-year term. The council, which consists of 18 members, acts as the governing body and Board of Directors for the SSO, guiding the Society’s strategic direction and managing its affairs. Founded in 1940 as the James Ewing Society, the SSO marks its 75th anniversary this year as the premier organization for surgeons and health care providers dedicated to advancing and promoting the science, education, and practice of cancer surgery worldwide. The 2,800-member Society’s focus on all solid-tumor disease sites is reflected in its Annual Cancer Symposium; monthly scientific journal, the Annals of Surgical Oncology; educational initiatives; and committee structure.

Fox Chase Recognized for Commitment to ACS

Fox Chase Cancer Center was honored with the Partners in Health Initiatives Award for its high level of commitment to the mission of ACS. The award is given to organizations that have demonstrated outstanding efforts to link ACS goals and priorities with the goals and priorities of the system that they represent.

Comments Off

Beck Receives Cancer Control Award

beckJ. Robert Beck, MD, senior vice president, deputy director, chief academic officer, chief administrative officer, and H.O. West and J.R. Wike Chair in Cancer Research at Fox Chase, received the 2014 Cancer Control Award. The award celebrates the spirit of volunteerism and work that advances cancer research, patient care, and advocacy. Beck oversees all activities that support Fox Chase’s academic and research operations. He also maintains research interests in technology assessment, cost-effectiveness of cancer therapies, cancer health disparities, and the organization of biomedical informatics services and general academic resources.

Comments Off

Farma Awarded Traveling Fellowship

farmaSurgical oncologist Jeffrey Farma, MD, FACS, was invited last fall to Germany as the 2014 American College of Surgeons (ACS) Traveling Fellow. The fellowship provided Farma with a better understanding of German surgical training and education and the country’s national health care system, specifically multidisciplinary cancer care and clinical trial procedures.

Farma visited six medical centers and attended the 131st Congress of the German Society for Surgery (GSS) in Berlin, where he presented in the session, “Changing the Treatment Paradigm for Locally Advanced Rectal Cancer.” During the Congress, he also talked about his experience as an ACS scholar and participated in a roundtable discussion on building relationships between GSS and ACS, an activity Farma plans to continue at Fox Chase.

Comments Off

Levy Receives Lifetime Achievement Award

levyThe American Academy of Hospice and Palliative Medicine has honored Michael H. Levy, MD, PhD, director of Fox Chase’s pain and palliative care program, with its 2015 Lifetime Achievement Award. The award recognizes Levy’s outstanding contributions and significant publications that have helped shape the field of hospice and palliative medicine. Levy, who is considered a leader of the American hospice and palliative care movement, is also chair of the NCCN Palliative Care Guidelines panel and a member of the Technical Advisory Panel for the first update of The Joint Commission’s palliative care standards.

Comments Off

Issa Given Scientific Research Award

pierre-issaJean-Pierre Issa, MD, co-leader of the cancer epigenetics group and director of the Fels Institute for Cancer Research and Molecular Biology at Temple University School of Medicine, was honored with the 2014 Scientific Research Award for his important contributions in the field of epigenetics in the pathophysiology and treatment of cancer. Issa has helped reveal that different cancers arise along different molecular routes, and his work has led to promising biomarkers for cancer detection, prognosis, and prediction. His proof-of-principle for epigenetic therapy of cancer is now standard of care in several types of leukemias.

Comments Off

Glusker Wins Procter Award

gluskerJenny P. Glusker, PhD, DSc, Fox Chase professor emerita, has been awarded the William Procter Prize for Scientific Achievement by Sigma Xi, The Scientific Research Society. The annual award recognizes researchers who have made outstanding scientific contributions and have communicated their significance across disciplines. Glusker’s research interests include cancer-causing chemicals, enzyme mechanisms, and crystallography.

Comments Off
Next Page »